MedTrace Logo

Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens

NCT01797783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2014-05-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to demonstrate substantial equivalence of the new DAILIES® AquaComfort Plus® Multifocal (DACP MF) contact lens to the commercially available Focus® DAILIES® Progressives (FDP) contact lens.

Conditions

Interventions

DEVICE

Nelfilcon A multifocal contact lens with comfort additive

DEVICE

Nelfilcon A multifocal contact lens

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Justin Webb, O.D. · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-04-30
Completion
2013-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01797783 on ClinicalTrials.gov